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Space flight is known to affect immune responses of astronauts and animals, 
decreasing lymphocytic responses to mitogenic stimuli, delayed typed hypersensitivity 
reactions, and T-cell activation. Despite changes in immune suppression, there are no 
reports of consistent adverse clinical events post flight.  To further investigate the 
spectrum of affected immune responses, murine splenocytes were stimulated 
immediately post-shuttle flight (14 days on STS-135) with T-cell stimulators or toll-like 
receptor agonists. Comparisons were made to ground control splenocytes from age-
matched mice. Cell phenotypes were assessed, as well as activation markers and 
associated cytokine production. The CD4+ population decreased with no concurrent 
decrease in CD8+ cells from shuttle mice post flight compared to ground controls. 
Regarding antigen presenting cell populations, the number of CD11c+ cells were slightly 
elevated post flight, compared to ground controls, with increased MHC Class I 
expression (I-Ab) and no change in Class II expression (H-2Kb).  CD86+ populations 
were also significantly diminished. However, the decreased markers did not correlate 
with activity. Stimulation of splenocytes post flight showed significant increase in bead 
uptake, increased Class I expression, increased TNF- a nd IL-6 production in response 
to TLR-2 (zymosan) and TLR-4 (LPS) agonists. While most activated (ConA or anti-
CD3/anti-CD28) CD4+ cells showed markedly diminished responses (reduced IL-2 
production), non-specific T cell responses to superantigen (SEA/SEB) increased post 
flight as determined by expression of early activation markers.  Production of additional 
cytokines was also dysregulated postflight.  Overall, persistent immune changes during 
space flight could represent unique clinical risks for exploration class missions. The 
consequences of pathogenic encounter remain an important concern that should be 
addressed.  
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